VSN-16
VSN-16 is a cannabinoid receptor agonist with vasodilatory activity. VSN-16 can be used for the study of multiple sclerosis[1].
Product Specifications
CAS Number
[863713-78-4]
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/vsn-16.html
Purity
99.31
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=CC(/C=C\CCCC(N(C)C)=O)=C1)NC(CO)C
Molecular Formula
C18H26N2O3
Molecular Weight
318.41
References & Citations
[1]P M Hoi, et al. Vascular pharmacology of a novel cannabinoid-like compound, 3- (5-dimethylcarbamoyl-pent-1-enyl) -N- (2-hydroxy-1-methyl-ethyl) benzamide (VSN16) in the rat. Br J Pharmacol. 2007 Nov;152 (5) :751-64.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15101702 1 Vial
Lentiviral human EPN1 shRNA (UAS) - Lentiviral human EPN1 shRNA (UAS, iRFP) (25)
Ask
View Details 
